Stefanie Andrea Erika Held

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke et al. · Blood · 2013 · 345 citations · Full text

Life Sciences, Immunology, Pharmacology +10

Generation and functional characterization of MDSC-like cells

Annkristin Heine, Stefanie Andrea Erika Held, Jonas Schulte-Schrepping et al. · OncoImmunology · 2017 · 48 citations · Full text

Life Sciences, Immunology, Pathology +16

The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib

Annkristin Heine, Judith Schilling, Barbara T. Grünwald et al. · Cancer Immunology Immunotherapy · 2016 · 42 citations · Full text

Medicine, Oncology, Pharmacology +15

Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products

Christina Berens, Annkristin Heine, Jens Müller et al. · Cytotherapy · 2016 · 35 citations

Life Sciences, Cell Biology, Molecular Biology +17

Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma

Ruth-Miriam Koerber, Stefanie Andrea Erika Held, Annkristin Heine et al. · Experimental Hematology and Oncology · 2015 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16